WuXi Biologics
Offering End-to-End Solutions
Antibody–Oligonucleotide Conjugates Landscape and WuXi XDC’s Capabilities in AOCs
Antibody–Oligonucleotide Conjugates (AOCs) represent an emerging and rapidly growing field within antibody-based biologics. The past few years have seen significant advancements in AOCs, driven by positive clinical results and key milestones achieved by leading companies in the AOC field . This deck provides the introduction and competitive landscape of AOCs as well WuXi XDC’s combabilities in AOCs and other bioconjugates.
Discuss This Content
To discuss this content, please complete the form on the following page to connect with our experts.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?